Open-Label Pilot Study of the Efficacy and Safety of Vusion Ointment for the Treatment of Intertrigo

• Status: Completed
• Trial end date: 2011-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if people with moist, red, patches on their skin in body folds would benefit treatment of those areas with an FDA-approved drug called Vusion.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Image Dermatology P.C.

Criteria

Inclusion Criteria:

• Evidence of intertrigo

Exclusion Criteria:

• Pregnancy

• Use of systemic or topical antifungal or corticosteroid treatment in the previous 14 days or during the 3-month treatment period

• allergy of sensitivity to Vusion

• undergoing warfarin anticoagulation

• alcohol or drug abuse

• Investigator determines they cannot particpate

• history of non-compliance or poor cooperation

• participation in an investigaitonal drug study within 30 days of Baseline Visit